ארצות הברית - אנגלית - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - febuxostat (unii: 101v0r1n2e) (febuxostat - unii:101v0r1n2e) - febuxostat tablets are xanthine oxidase (xo) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable. febuxostat tablets are not recommended for the treatment of asymptomatic hyperuricemia.   febuxostat tablets are xanthine oxidase (xo) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable. for the safe and effective use of allopurinol, see allopurinol prescribing information. limitations of use: febuxostat tablets are not recommended for the treatment of asymptomatic hyperuricemia.   febuxostat is contraindicated in patients being treated with azathioprine or merca

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - febuxostat - film-coated tablet - 120 milligram(s) - preparations inhibiting uric acid production; febuxostat

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - febuxostat - film-coated tablet - 80 milligram(s) - preparations inhibiting uric acid production; febuxostat

ארצות הברית - אנגלית - NLM (National Library of Medicine)

ascend laboratories, llc - febuxostat (unii: 101v0r1n2e) (febuxostat - unii:101v0r1n2e) - febuxostat tablet is a xanthine oxidase (xo) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable. for the safe and effective use of allopurinol, see allopurinol prescribing information. limitations of use: febuxostat tablet is not recommended for the treatment of asymptomatic hyperuricemia. febuxostat is contraindicated in patients being treated with azathioprine or mercaptopurine [see drug interactions (7)]. risk summary limited available data with febuxostat use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes. no adverse developmental effects were observed in embryo-fetal development studies with oral administration of febuxostat to pregnant rats and rabbits during organogenesis at doses that produced maternal exposures up to 40 and 51 times,

בלגיה - אנגלית - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - febuxostat hemihydrate 82 mg - eq. febuxostat 80 mg - film-coated tablet - 80 mg - febuxostat hemihydrate 82 mg - febuxostat

בלגיה - אנגלית - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - febuxostat hemihydrate 123,4 mg - eq. febuxostat 120 mg - film-coated tablet - 120 mg - febuxostat hemihydrate 123.4 mg - febuxostat

בלגיה - אנגלית - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - febuxostat hemihydrate 82,28 mg - eq. febuxostat 80 mg - film-coated tablet - 80 mg - febuxostat hemihydrate 82.28 mg - febuxostat

בלגיה - אנגלית - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - febuxostat hemihydrate 123,42 mg - eq. febuxostat 120 mg - film-coated tablet - 120 mg - febuxostat hemihydrate 123.42 mg - febuxostat

בלגיה - אנגלית - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - febuxostat hemihydrate 123,42 mg - eq. febuxostat 120 mg - film-coated tablet - 120 mg - febuxostat hemihydrate 123.42 mg - febuxostat

בלגיה - אנגלית - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - febuxostat hemihydrate 82,28 mg - eq. febuxostat 80 mg - film-coated tablet - 80 mg - febuxostat hemihydrate 82.28 mg - febuxostat